Burning Rock Biotech
BNR
18 hedge funds and large institutions have $6.69M invested in Burning Rock Biotech in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 18 → 18 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0.09% less ownership
Funds ownership: 20.05% → 19.96% (-0.09%)
38% less capital inflows, than outflows
Capital inflows: $98.5K | Capital outflows: $158K
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$80.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.18K |
| 3 |
Millennium Management
New York
|
+$8.97K |
| 4 |
Blue Trust Inc
Alpharetta,
Georgia
|
+$138 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Redwood Wealth Management Group
Medford,
New Jersey
|
-$69.3K |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$32K |
| 3 |
Morgan Stanley
New York
|
-$30.7K |
| 4 |
Nikko Asset Management Americas
New York
|
-$10.7K |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
-$10.7K |
BNR Hedge Fund Activity: Q3 2024 in Review
18 of the 6,989 institutional investors tracked by Wall St. Rank reported a position in Burning Rock Biotech (BNR) for Q3 2024, worth a combined $6.69M — down 49% from $13.2M a quarter earlier.
Fund positioning in BNR was balanced in Q3 2024: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 7 trimmed.
The largest buyer was Kynam Capital Management, adding an estimated $80.2K. The largest seller was Redwood Wealth Management Group, exiting entirely with an estimated $69.3K sold.
- 18 institutional investors held Burning Rock Biotech (BNR) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $6.69M of Burning Rock Biotech stock for Q3 2024, down 49% quarter-over-quarter.
- 1 fund opened new Burning Rock Biotech positions in Q3 2024 and 1 closed out, a net change of 0 holders.
- The largest Burning Rock Biotech buyer in Q3 2024 was Kynam Capital Management, an estimated $80.2K added.
- The largest Burning Rock Biotech seller in Q3 2024 was Redwood Wealth Management Group, an estimated $69.3K sold.
Based on aggregated 13F filings for Q3 2024.